Showing results (271-280 of 290) with videos related to
Sort By:
Pageof 29
The New England Journal of Medicine|September 15, 2016
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder CancerGopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.European Urology Focus|June 20, 2021
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic ReviewLisa Moris, Giorgio Gandaglia, Antoni Vilaseca, et al.European Urology Focus|June 29, 2019
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel RecommendationsThomas Van den Broeck, Roderick C N van den Bergh, Erik Briers, et al.British Journal of Cancer|July 17, 2020
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancerSian M Noble, Kirsty Garfield, J Athene Lane, et al.Critical Reviews in Oncology/Hematology|June 21, 2015
Prostate Cancer Unit Initiative in Europe: A position paper by the European School of OncologyRiccardo Valdagni, Hendrik Van Poppel, Michael Aitchison, et al.The New England Journal of Medicine|March 20, 2018
MRI-Targeted or Standard Biopsy for Prostate-Cancer DiagnosisVeeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, et al.European Urology|May 8, 2021
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate CancerThomas Van den Broeck, Daniela Oprea-Lager, Lisa Moris, et al.European Urology|October 11, 2016
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT TrialThomas J Johnston, Greg L Shaw, Alastair D Lamb, et al.Pageof 29